Newcastle University is part of a new national network which will accelerate innovation across nucleic acids such as DNA and ...
Pooled analysis of 90 subjects across 5 trials shows stable mean ejection fraction and no clinically significant left ventricular dysfunction Data demonstrates Annamycin addresses the principal barrie ...
Boehringer Ingelheim has put up 407.5 million euros ($478 million) in biobucks to secure global rights to a first‑in‑class ...
Advancements in healthcare, digital transformation and capital formation helped the UAE secure 15th place in a Global AI ...
Pooled analysis of 90 subjects across 5 trials shows stable mean ejection fraction and no clinically significant left ...
Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, ...
Insilico Medicine (Insilico, 03696.HK), a biotechnology company powered by generative artificial intelligence, today ...
Immunogenicity dragged on the efficacy of AstraZeneca’s rare endocrine disorder prospect in a phase 3 trial, causing the $800 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results